Riskpilot← Back to searchSign inGet full accessApoKare Pharma AB
ABActiveOrg 5594410283Blåsippsbacken 97General medical practice activities · NACE 8621Est. 20239 employees
Revenue 2025
SEK 11M
EBITDA margin
9.1%
Equity ratio
40.8%
Financial strength
Net profit 2025
SEK 791K
9 employees
| Revenue | SEK 11M | — |
| EBITDA | SEK 996K | — |
| Net profit | SEK 791K | — |
| Total assets | SEK 4M | — |
| Equity | SEK 1,6M | — |
| Employees | 9 | — |
Legal name
ApoKare Pharma AB
Org number
5594410283
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
6 juli 2023
Share capital
SEK 25 000
Employees
9 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall bedriva konsultverksamhet inom hälso- och sjukvård och därmed förenlig verksamhet.
Address
Blåsippsbacken 97
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2024 | 2025 |
|---|---|---|
| Revenue | — | 10 986 |
| Staff expenses | — | −9 214 |
| EBITDA | 0 | 996 |
| Depreciation & amort. | — | 2 |
| EBIT | 0 | 998 |
| Net financials | — | −1 |
| Profit before tax | 0 | 998 |
| Tax | — | −206 |
| Net profit | — | 791 |
| Item | 2024 | 2025 |
|---|---|---|
| Total assets | — | 4 029 |
| Equity | — | 1 644 |
| Long-term debt | — | — |
| Short-term debt | — | 2 385 |
| Total debt | — | 2 385 |
EBITDA margin
9.1%
This company
15.8%
Market median
-42% vs market
20242025
Equity ratio
40.8%
This company
38.2%
Market median
+7% vs market
20242025
Return on equity
48.1%
This company
18.4%
Market median
+161% vs market
20242025
Net profit margin
7.2%
This company
8.1%
Market median
-11% vs market
20242025
Asset turnover
2.73×
This company
1.12×
Market median
+144% vs market
20242025
Debt / equity
1.45×
This company
0.62×
Market median
-134% vs market
20242025
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
RT Chief Executive Officer | Chief Executive Officer | 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2023 | |
| Former (3) | ||
| Deputy Board Member | 2023 – 2023 | |
| Deputy Board Member | 2023 – 2023 | |
| Board of Directors | 2023 – 2023 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ApoKare Pharma AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Rasha Taleb Jamil | Chief Executive Officer | 0 companies |
| Stina Maria Selldén | Deputy Board Member | 0 companies |
| Karar Ali Kareem | Deputy Board Member | 0 companies |
| Erik Alexander Stötsberg | Deputy Board Member | 0 companies |
| Mikaela Jenni Berglund | Board of Directors | 0 companies |